E2F3 Human siRNA Oligo Duplex (Locus ID 1871)

SKU
SR319978
E2F3 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
  $518.00
3 Weeks*
Specifications
Specifications
Product Data
Purity HPLC purified
Quality Control Tested by ESI-MS
Sequences Available with shipment
Components
E2F3 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each (Locus ID 1871)
Included - SR30004, Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmol
Included - SR30005, RNAse free siRNA Duplex Resuspension Buffer - 2 ml
Stability One year from date of shipment when stored at -20°C.
Shipping Ambient
# of Transfections Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM).
Note Single siRNA duplex (10nmol) can be ordered.
Reference Data
RefSeq NM_001243076, NM_001949
UniProt ID O00716
Synonyms E2F-3
Summary This gene encodes a member of a small family of transcription factors that function through binding of DP interaction partner proteins. The encoded protein recognizes a specific sequence motif in DNA and interacts directly with the retinoblastoma protein (pRB) to regulate the expression of genes involved in the cell cycle. Altered copy number and activity of this gene have been observed in a number of human cancers. There are pseudogenes for this gene on chromosomes 2 and 17. Alternative splicing results in multiple transcript variants. provided by RefSeq, Mar 2013
Performance Guaranteed OriGene guarantees that at least two of the three Dicer-Substrate duplexes in the kit will provide at least 70% or more knockdown of the target mRNA when used at 10 nM concentration by quantitative RT-PCR when the TYE-563 fluorescent transfection control duplex (cat# SR30002) indicates that >90% of the cells have been transfected and the HPRT positive control (cat# SR30003) provides 90% knockdown efficiency.

For non-conforming siRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the siRNA kit. To arrange for a free replacement with newly designed duplexes, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled siRNA control (quantitative RT-PCR data required).
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Targeting PAX8 sensitizes ovarian cancer cells to ferroptosis by inhibiting glutathione synthesis
Luo, Liu, Chen et al
Apoptosis (2024)
Cited by 21
AI Summary: In this study, OriGene's siRNAs targeting GCLC (SR320300) and PAX8 (SR322280) were used to investigate the roles of these genes in ferroptosis resistance and sensitivity in ovarian cancer cells.
Snippet: siRNA-1 (sc-29288) and siRNA-2 (SR300631), E2F3 siRNA-1(sc-37817) and siRNA-2 (SR319978), PRAD6B siRNA-1 (sc-62751) and siRNA-2 (SR313575), GCLC siRNA (SR320300), PAX8 siRNA-1 and siRNA-2 (SR322280) were acquired from Santa Cruz and Origene corporation
Showing 1-1 of 1 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products